Clear the Air With New COPD Guidelines
February 2026
Patients with COPD will start daily inhalers sooner...as part of the updated GOLD guidelines to improve symptoms and decrease mortality.
For acute symptom relief in all patients with COPD, continue to recommend a prn short-acting beta-agonist (SABA), such as salbutamol...or a short-acting muscarinic antagonist (SAMA), such as ipratropium.
A SABA/SAMA combo can improve symptoms over either a SABA or SAMA alone...and may mitigate side effects from higher doses of single agents.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive